The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
HER-2 B Cell Peptide Vaccine
- Status
- RECRUITING
- Phase
- PHASE1
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
- Status
- COMPLETED
- Phase
- N/A
Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
- Status
- RECRUITING
- Phase
- PHASE2
The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
- Status
- RECRUITING
- Phase
- NA
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases
- Status
- RECRUITING
- Phase
- NA
A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
- Status
- RECRUITING
- Phase
- NA
Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
- Status
- RECRUITING
- Phase
- N/A
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real World Patient-Reported Outcomes in Chinese Her2+ EBC Patients Receiving (Neo) Adjuvant Anti-Her2 Based Therapy
- Status
- RECRUITING
- Phase
- N/A
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- NA